Jove
Visualize
Contact Us

Related Experiment Videos

Update: clinically significant cytochrome P-450 drug interactions

E L Michalets1

  • 1Department of Pharmacy, Mission-St. Joseph's Health System, and the University of North Carolina School of Pharmacy Community-Based Practice, Asheville 28801, USA.

Pharmacotherapy
|February 20, 1998
PubMed
Summary

Understanding cytochrome P-450 (CYP450) enzymes is crucial for predicting dangerous drug interactions. Key CYP450 isoenzymes like CYP3A4, CYP2D6, CYP1A2, and CYP2C are vital for drug metabolism.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Midodrine for the weaning of vasopressor infusions.

Journal of clinical pharmacy and therapeutics·2016
Same author

Reimbursement for pharmacists' cognitive services in the inpatient setting.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2001
Same author

Drug interactions with cisapride: clinical implications.

Clinical pharmacokinetics·2000
Same author

Torsade de pointes resulting from the addition of droperidol to an existing cytochrome P450 drug interaction.

The Annals of pharmacotherapy·1998
Same author

Diltiazem-associated thrombocytopenia.

Pharmacotherapy·1997
Same author

Pharmacokinetics of vancomycin in adult cystic fibrosis patients.

Antimicrobial agents and chemotherapy·1996
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Pharmacology
  • Biochemistry
  • Drug Metabolism

Background:

  • Recent technological advancements have led to extensive data on cytochrome P-450 (CYP450) isoenzymes.
  • There is growing awareness of severe drug interactions involving common medications and CYP450 enzymes.

Purpose of the Study:

  • To highlight the importance of understanding CYP450 substrates, inhibitors, and inducers.
  • To emphasize the role of CYP450 isoenzymes in predicting drug interactions.

Main Methods:

  • Review of current information on CYP450 isoenzymes.
  • Identification of major human CYP450 isoenzymes involved in drug metabolism.

Main Results:

  • Knowledge of substrates, inhibitors, and inducers aids in predicting drug interactions.

Related Experiment Videos

  • Microsomal drug metabolism is influenced by genetic variations, age, diet, liver disease, and endogenous compounds.
  • Major drug-metabolizing CYP450 isoenzymes include CYP3A4, CYP2D6, CYP1A2, and the CYP2C subfamily.

    • Conclusions:

    • Understanding CYP450 enzyme activity is essential for safe medication use.
    • Factors beyond induction and inhibition, such as genetics and physiological conditions, impact drug metabolism.